Literature DB >> 10994173

[Clinical diagnosis of salivary gland sarcoidosis (Heerfordt syndrome)].

C Sagowski1, J Ussmüller.   

Abstract

Sarcoidosis, a systemic granulomatous disease of unknown cause, may involve any body organ. The most common manifestation in the head-neck area is lymph node sarcoidosis or, alternatively, Heerfordt's syndrome (with involvement of lacrimal and parotid gland and possible facial palsy). Far less common is a isolated laryngeal sarcoidosis. The typical histopathological appearance proves the diagnosis. However, obtaining representative and sufficient biopsy material in some cases may carry risks for the patients or might technically be difficult. In these cases, the clinician can fall back on two other, noninvasive diagnostic procedures: ACE level activity determination in blood serum and 67gallium citrate scintigraphy. Elevated ACE levels in combination with a positive 67gallium scintigraphy have a specificity (combined) of 99%. As a valuable side effect, this procedure sensitively may discover additional disease in the body and also serves well as a therapy-control examination. The presented case report shows clearly that these clinical methods, if combined, are sufficient for diagnosis of Heerfordt's syndrome/sarcoidosis; no additional histopathological examination is required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994173     DOI: 10.1007/s001060050624

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  2 in total

1.  [A rare manifestation of sarcoidosis].

Authors:  A Fieß; I Frisch; S Wicht; P Hofstetter; M Knuf; J Gosepath; S Scheil-Bertram; U H Steinhorst
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

2.  [Use of state-of-the-art ultrasound techniques in diagnosing sarcoidosis of the salivary glands (Heerfordt's syndrome)].

Authors:  T Fischer; M Mühler; D Beyersdorff; H Guski; M Bollow; B Hamm; M Werbs; S Filimonow
Journal:  HNO       Date:  2003-03-27       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.